Paper336393
Isolation and characterization of a mocimycin resistant mutant of Escherichia coli with an altered elongation factor EF-Tu.
van de Klundert JA and 4 others. FEBS Lett, 1977. Cited by 39 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Isolation and characterization of a mocimycin resistant mutant of Escherichia coli with an altered elongation factor EF-Tu. Papers, record 336393. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/336393
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Isolation and characterization of a mocimycin resistant mutant of Escherichia coli with an altered elongation factor EF-Tu.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Escherichia coli | Major topic |
| Bacterial Proteins | |
| Drug Resistance, Microbial | |
| Mutation | |
| Peptide Biosynthesis | |
| Peptide Elongation Factors | |
| Pyridones | |
| Transduction, Genetic |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 12,692,092 | Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria. | Clin Microbiol Rev | 2003 | https://conductscience.org/library/papers/12692092 | PubMed |
| 8,416,899 | A single amino acid substitution in elongation factor Tu disrupts interaction between the ternary complex and the ribosome. | J Bacteriol | 1993 | https://conductscience.org/library/papers/8416899 | PubMed |
| 7,001,448 | Elongation factor Tu isolated from Escherichia coli mutants altered in TufA and tufB. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/7001448 | PubMed |
| 6,323,160 | Specific alterations of the EF-Tu polypeptide chain considered in the light of its three-dimensional structure. | EMBO J | 1984 | https://conductscience.org/library/papers/6323160 | PubMed |
| 3,540,529 | Mutant EF-Tu increases missense error in vitro. | Mol Gen Genet | 1986 | https://conductscience.org/library/papers/3540529 | PubMed |
| 3,515,126 | The isolation and mapping of EF-Tu mutations in Salmonella typhimurium. | Mol Gen Genet | 1986 | https://conductscience.org/library/papers/3515126 | PubMed |
| 3,327,691 | Mutants of elongation factor Tu promote ribosomal frameshifting and nonsense readthrough. | EMBO J | 1987 | https://conductscience.org/library/papers/3327691 | PubMed |
| 2,050,625 | Mutant ribosomes can generate dominant kirromycin resistance. | J Bacteriol | 1991 | https://conductscience.org/library/papers/2050625 | PubMed |
| 360,222 | Mutants of Escherichia coli altered in both genes coding for the elongation factor Tu. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/360222 | PubMed |
| 356,046 | Direct demonstration of duplicate tuf genes in enteric bacteria. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/356046 | PubMed |
| 99,428 | Genetic and biochemical characterization of kirromycin resistance mutations in Bacillus subtilis. | J Bacteriol | 1978 | https://conductscience.org/library/papers/99428 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/336393
GET https://conductscience.org/api/papers/v1/336393/authors